Science, Politics, and Health: The Environmental Protection Agency at the Threshold

Schwartz, Joel; on behalf of the International Society for Environmental Epidemiology

doi: 10.1097/EDE.0000000000000624
From the ISEE
ISEE

From the Departments of Environmental Health and Epidemiology, Harvard TH Chan School of Public Health, Boston, MA.

Schwartz was a recipient of a John D and Catherine T MacArthur Fellowship.

Dr. Schwartz has received research grants from the US Environmental Protection Agency and the National Institute for Environmental Health Sciences. Those grants are awarded based on recommendations from outside peer review panels. Dr. Schwartz has testified on the health effects of air pollution in law suits brought by the US Department of Justice.

Correspondence: Joel Schwartz, 401 Park Dr, Suite 404H West, P.O. Box 15677, Boston, MA 02215. E-mail:joel@hsph.harvard.edu.

Article Outline

The United States Environmental Protection Agency (EPA) was founded in 1970 with bipartisan support and under a Republican president, Richard Nixon. The central laws authorizing it to protect the health of US residents from pollution (the Clean Air Act, the Safe Drinking Water Act, etc.) similarly enjoyed bipartisan support. Beginning in the 1980s this began to change, with increased ideological opposition to regulation. In the 1980s that opposition focused on arguments that the costs of pollution controls were not justified by the modest health impacts produced. This opposition was generally accompanied by the argument that more science is needed. However, by the late 1990s, these arguments became untenable, because the science had been done, and the impacts were not modest.

First PM2.5 and more recently ozone have been shown to be associated with substantial health risks; these include early deaths and myocardial infarctions; and hospital admissions for pneumonia, heart attacks, and stroke show similar associations.1–6 The estimated attributable health impact is large. Using dose–response curves vetted by EPA’s Science Advisory Board, Fann et al.7 estimated that PM2.5 was associated with 130,000 early deaths in 2005, 180,000 nonfatal myocardial infarctions, and 2.5 million asthma exacerbations. The associations in the epidemiology studies used have been replicated in dozens of cohort studies and hundreds of time-series studies across the world. The World Health Organization has used them in the Global Burden of Disease estimates, reporting over 5 million of early deaths per year due to these pollutants.8 The Royal College of Physicians similarly estimated 40,000 deaths per year in the United Kingdom due to air pollution.9

A large number of toxicology and controlled human exposure studies showing associations of these pollutants with changes in intermediary outcomes (blood pressure, inflammation, autonomic function, endothelial function, thrombosis, oxygen uptake, etc.) provide support to those findings.10–17 Similar results have been reported in panel studies of humans.18–22 A double-blinded study using true versus sham particle filters in residences demonstrated that lowering particle levels decreased inflammatory markers and increased methylation of proinflammatory genes.23 More recently, causal modeling methods have added to the evidence.24,25 This body of evidence is too large to be reviewed here, but it has been reviewed by expert scientific committees convened by multinational (e.g., the World Health Organization, the UN Environment Program, the European Union), as well as national governments, such as the United Kingdom, and EPA’s own external Clean Air Scientific Advisory Board. All these review groups, as well as major medical organizations such as the American Heart Association, the American College of Cardiology, etc., have supported the scientific consensus that these are causal effects.8,26–36

This scientific consensus is at odds with political beliefs that place centrality on not limiting the behavior of people or businesses except under extreme circumstances. Groups who hold these beliefs can only resolve this conflict by attacking the science and, when that fails, attacking the enterprise of science itself.

The International Society for Environmental Epidemiology is deeply concerned by the prospect that Scott Pruitt—a person who seems to hold these antiscience beliefs—has been nominated to head the EPA, the very agency that sets environmental health standards based on science. As Attorney General of Oklahoma, Scott Pruitt dissolved the branch that dealt with enforcing environmental regulations and replaced it with a “federalism” branch, which has sued EPA over almost all major air pollution regulations.37 He advocates a policy of leaving such decisions to states, despite the knowledge, obvious to anyone who has watched a weather map on the evening news, that air travels great distances, and pollution with it.

When his appointment was announced, Mr. Pruitt stated that “The American people are tired of seeing billions of dollars drained from our economy due to unnecessary EPA regulations, and I intend to run this agency in a way that fosters both responsible protection of the environment and freedom for American businesses.”38

However, based on the lawsuits that he has brought against the EPA in his term as Attorney General of Oklahoma, the regulations he dislikes, far from being “unnecessary,” are essential for protecting human health. Indeed, they have saved over 10,000 lives per year since their implementation. These include the cross-state air pollution rule, the primary driver of recent reductions in PM2.5 in the United States,39 and the Mercury and Air Toxics rule, which has also reduced particle concentrations in the air and mercury in seafood.40 Moreover, rather than being a drain on the US economy, these rules have economic benefits that far exceed their cost. For example, the Regulatory Impact Analysis for the Cross State Air Pollution rule found economic benefits were more than 100 times the costs.41 Importantly, the methodologies and economic analyses that reach those conclusions were reviewed by an external panel of internationally known environmental economists, and the health effects they were based on were reviewed by an external panel of similarly distinguished experts in environmental health.33,42

To justify their objections to environmental protection rules, conservatives assert that the “health evidence is weak,”43 that failure to release medical records of study participants to industry groups means EPA relies on “secret science,”44 and that allowing scientists with expertise on environmental health to serve on review committees is a “conflict of interest” because they are “reviewing their own studies45” (although each member of the Clean Air Scientific Advisory Committee has written only a small percentage of the thousands of papers reviewed). The US House of Representatives has even passed a bill that states “Board members may not participate in advisory activities that directly or indirectly involve review or evaluation of their own work” while allowing industry scientists with true conflicts of interest to take part in the review (“persons with substantial and relevant expertise are not excluded from the Board due to affiliation with or representation of entities that may have a potential interest in the Board’s advisory activities”).45 Moreover, scientists who have received grants are prohibited from serving on EPA’s Scientific Advisory Board, which would exclude essentially all nonindustry funded independent scientists with expertise in relevant areas.45

Increasingly, attempts are being made to reduce funding for science and for the scientific review apparatus that keeps producing what conservatives view as undesired results. A recent attempt to cut funding for the International Agency for Research on Cancer (IARC) and calls for reducing EPA’s research budget are examples. These attempts are also accompanied by personal attacks on scientists. The House Science Committee recently criticized EPA, stating that “The committee has also determined that EPA officials maintained a close relationship with activist IARC participant Christopher Portier.”46 From this description, one might think EPA conspired with a wild-eyed environmentalist. In fact, Dr. Portier is the former Director of the National Center for Environmental Health at the Centers for Disease Control and Prevention (CDC) and former Director of the Agency for Toxic Substances and Disease Registry. Before CDC, Dr. Portier was Associate Director of the National Institute of Environmental Health Sciences. These are the same types of attacks used to attack climate scientists and to create the impression of uncertainty around the earth-warming effects of human emissions of CO2 and methane; in a May Editorial in the National Review, Mr. Pruitt stated “Healthy debate is the lifeblood of American democracy, and global warming has inspired one of the major policy debates of our time. That debate is far from settled. Scientists continue to disagree about the degree and extent of global warming and its connection to the actions of mankind.”47

Mr. Pruitt’s campaign and an organization of like-minded state Attorneys-General he helped to found raise considerable funds from companies that make similar statements, and oppose pollution control regulations. He recently sent a letter written for him by an oil company to EPA, complaining about estimation of pollution from oil wells.48 In another letter, he asked the Inspector General of EPA to stop the agency from investigating the possible impacts of fracking on drinking water,49 which suggests he favors a policy of “don’t look and you won’t find a problem.” This year he sued the agency to overturn a regulation of methane emissions from new equipment used at oil and gas wells.50

Pruitt’s background and record make him an inappropriate choice for leader of an agency tasked with protecting human health and the environment and, indeed, ensuring that the United States is a leader in protecting the global environment. The International Society for Environmental Epidemiology therefore urges the President-Elect to withdraw Pruitt’s nomination or the US Senate to reject the nomination.

Back to Top | Article Outline

ABOUT THE AUTHOR

JOEL SCHWARTZ is a Professor in the Departments of Environmental Health and Epidemiology at the Harvard School of Public Health, on the steering committee of the Harvard University Center for the Environment, and Director of the Harvard Center for Risk Analysis. His major research interests include health effects of air pollution, of heavy metals, climate change, and drinking water. He addresses this using environmental epigenetics, gene–environment interaction studies, exposure modeling, including both land use regression approaches, as well as use of remote sensing data and chemical transport models, and in methodological studies, including dose–response modeling, causal modeling, and data fusion.

Back to Top | Article Outline

REFERENCES

1. Crouse DL, Peters PA, Hystad P, et al. Ambient PM2.5, O3, and NO2 exposures and associations with mortality over 16 years of follow-up in the Canadian Census Health and Environment Cohort (CanCHEC). Environ Health Perspect. 2015;123:1180–1186.
2. Shi L, Zanobetti A, Kloog I, et al. Low-concentration PM2.5 and mortality: estimating acute and chronic effects in a population-based study. Environ Health Perspect. 2016;124:46–52.
3. Hart JE, Liao X, Hong B, et al. The association of long-term exposure to PM2.5 on all-cause mortality in the Nurses’ Health Study and the impact of measurement-error correction. Environ Health. 2015;14:38.
4. Turner MC, Jerrett M, Pope Iii CA, et al. Long-term ozone exposure and mortality in a large prospective study. Am J Respir Crit Care Med. 2015;193:1134–1142.
5. Beelen R, Raaschou-Nielsen O, Stafoggia M, et al. Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE project. Lancet. 2014;383:785–795.
6. Chen Y, Ebenstein A, Greenstone M, Li H. Evidence on the impact of sustained exposure to air pollution on life expectancy from China’s Huai River policy. Proc Natl Acad Sci U S A. 2013;110:12936–12941.
7. Fann N, Lamson AD, Anenberg SC, Wesson K, Risley D, Hubbell BJ. Estimating the national public health burden associated with exposure to ambient PM2.5 and ozone. Risk Anal. 2012;32:81–95.
8. Forouzanfar MH, Alexander L, et al; Collaborators GBDRF, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–2323.
9. Royal College of Physicians. Every breath we take: the lifelong impact of air pollution. Report of a working party. 2016.
10. Bartoli CR, Wellenius GA, Diaz EA, et al. Mechanisms of inhaled fine particulate air pollution-induced arterial blood pressure changes. Environ Health Perspect. 2009;117:361–366.
11. Langrish JP, Mills NL, Chan JK, et al. Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol. 2009;6:8.
12. Lundbäck M, Mills NL, Lucking A, et al. Experimental exposure to diesel exhaust increases arterial stiffness in man. Part Fibre Toxicol. 2009;6:7.
13. Fakhri AA, Ilic LM, Wellenius GA, et al. Autonomic effects of controlled fine particulate exposure in young healthy adults: effect modification by ozone. Environ Health Perspect. 2009;117:1287–1292.
14. Matsumoto G, Nakagawa NK, Vieira RP, et al. The time course of vasoconstriction and endothelin receptor A expression in pulmonary arterioles of mice continuously exposed to ambient urban levels of air pollution. Environ Res. 2010;110:237–243.
15. O’Toole TE, Hellmann J, Wheat L, et al. Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res. 2010;107:200–203.
16. Peretz A, Sullivan JH, Leotta DF, et al. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect. 2008;116:937–942.
17. Calderón-Garcidueñas L, Solt AC, Henríquez-Roldán C, et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol. 2008;36:289–310.
18. Bind MA, Peters A, Koutrakis P, Coull B, Vokonas P, Schwartz J. Quantile regression analysis of the distributional effects of air pollution on blood pressure, heart rate variability, blood lipids, and biomarkers of inflammation in elderly American Men: The Normative Aging Study. Environ Health Perspect. 2016;124:1189–1198.
19. Peng C, Luttmann-Gibson H, Zanobetti A, et al. Air pollution influences on exhaled nitric oxide among people with type II diabetes. Air Qual Atmos Health. 2016;9:265–273.
20. Romieu I, Barraza-Villarreal A, Escamilla-Nuñez C, et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol. 2008;121:903–9.e6.
21. Ruckerl R, Greven S, Ljungman P, et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect. 2007;115:1072–1080.
22. Delfino RJ, Staimer N, Gillen D, et al. Personal and ambient air pollution is associated with increased exhaled nitric oxide in children with asthma. Environ Health Perspect. 2006;114:1736–1743.
23. Chen R, Zhao A, Chen H, et al. Cardiopulmonary benefits of reducing indoor particles of outdoor origin: a randomized, double-blind crossover trial of air purifiers. J Am Coll Cardiol. 2015;65:2279–2287.
24. Wang Y, Kloog I, Coull BA, Kosheleva A, Zanobetti A, Schwartz JD. Estimating causal effects of long-term PM2.5 exposure on mortality in New Jersey. Environ Health Perspect. 2016;124:1182–1188.
25. Schwartz J, Bind MA, Koutrakis P. Estimating causal effects of local air pollution on daily deaths: effect of low levels. Environ Health Perspect. 2017;125:23–29.
26. World Health Organization. Health effects of particulate matter: policy implications for countries in Eastern Europe, Caucasus and central Asia. 2013.
27. World Health Organization. WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide. 2006.Geneva, Switzerland: World Health Organization.
28. Brook RD, Rajogopalan S, Pope CA, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331–2378.
29. European Respiratory Society. Air Quality and Health. 2010.
30. American Thoracic Society. ATS Policy Brief on Clean Air. 2016.
31. Program UNE. Integrated Assessment of Black Carbon and Tropospheric Ozone: Summary for Decision Makers. 2011.Nairobi: United Nations.
32. Committee CASA. Letter to Administrator of EPA. 2006;EPA-CASAC-LTR-06-003.
33. CASAC. letter of 9/10/2010 to the Administrator of EPA. 2010;EPA-CASAC-10–015.
34. European Commission. Impact assessment for A Clean Air Program for Europe. 2013.
35. American Thoracic Society, American Lung Association, American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Cancer Society, American Public Health Association and Health NAoLBo. Comments on the National Ambient Air Quality Standard for PM2.5. 2006.
36. American Thoracic Society, American Medical Association, American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation, National Association for the Medical Direction of Respiratory Care, Medicine ACoOaE and Medicine ACoP. National Ambient Air Quality Standards for Ozone. 2007.
40. Office of Air and Radiation OoAQPaS, Health and Environmental Impacts Division. Regulatory Impact Analysis for the Final Mercury and Air Toxics Standards. 2011. Accessed December 2016.
42. Science Advisory Board. Review of EPA’s DRAFT Health Benefits of the Second Section 812 Prospective Study of the Clean Air Act. 2010;EPA-COUNCIL-10-001. Accessed December 2016.
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.